The following article has been retrieved from the archive and no longer contains the original video.
French drugmaker Sanofi-Aventis has swine flu to thank for an improved outlook for 2009. The group said it expected H1N1 vaccines to add around 337 million euros to sales in the fourth quarter alone and sees that continuing into next year. Its earnings per share for the quarter just gone increased over 16 percent on the back of cost cutting measures.
Copyright © 2009 euronews
tags: pharmaceutical companies
Top Stories & Breaking News


A fifth of jobs could be cut at Opel
Lloyds to offer slashed price for shares
Dexia could merge with Societe Generale
Cadbury shares hit record high after rival bids
Microsoft deal with News Corps may exclude Google
Severstal’s surprise profit
Ahold to cut costs
Bad fuel hedge hit easyJet profit
UBS targets profit through transformation
Cadbury to partner with Ferrero? 








